Prevalence and Factors Associated with Reduced Kidney Function among Patients with Type 2 Diabetes Mellitus Attending the Specialized Diabetes Clinic at Khon Kaen Hospital.
Keywords:
Type 2 diabetes mellitus, Reduced kidney function, Prevalence, Factors associated with reduced kidney functionAbstract
This survey research by cross-sectional analytical study among 340 patients with type 2 diabetes mellitus aimed to determine the prevalence of and identify factors associated with reduced kidney function among patients receiving care at the Specialized Diabetes Clinic, Khon Kaen Hospital. Participants were recruited through simple random sampling from a total population of 1,603 patients, and data were retrieved from electronic medical records. Reduced kidney function was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m². Data were analyzed using descriptive statistics and multiple logistic regression analysis.
The results demonstrated that the prevalence of reduced kidney function (eGFR < 60 mL/min/1.73 m²) was 35.00% (119 patients). Factors significantly associated with reduced kidney function were the presence of albuminuria (aOR = 5.53, 95% CI: 3.12–9.82), age ≥ 60 years (aOR = 4.23, 95% CI: 2.15–8.31), duration of diabetes ≥ 10 years (aOR = 3.43, 95% CI: 1.84–6.39), and systolic blood pressure ≥ 140 mmHg (aOR = 2.05, 95% CI: 1.12–3.75).
References
International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium; 2021.
สมาคมโรคเบาหวานแห่งประเทศไทย. แนวทางเวชปฏิบัติสำหรับโรคเบาหวาน 2566. กรุงเทพฯ: ศรีเมืองการพิมพ์; 2566.
Kitiyakara C, et al. The epidemiology of chronic kidney disease in Thailand. Nephrology. 2020;25(10):735-42.
Thai Renal Outcomes Network. Annual Report Thailand Renal Replacement Therapy. Bangkok; 2022.
Heerspink HJL, et al. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice. Kidney Int. 2018;94(1):167-76.
American Diabetes Association. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023. Diabetes Care. 2023;46(Supp 1):S191-202.
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(4S):S1-127.
Khon Kaen Hospital. Annual Statistics Report 2023. Khon Kaen: Medical Informatics Department; 2023.
Rawdaree P, et al. Prevalence of chronic kidney disease in Thai patients with type 2 diabetes mellitus. J Med Assoc Thai. 2012;95(9):1141-9.
Mogensen CE. Microalbuminuria and hypertension in determining the evolution of diabetic nephropathy. Diabet Med. 2017;34(11):1498-505.
Denic A, et al. The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging. J Am Soc Nephrol. 2017;28(1):313-20.
Yamagishi S, Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev. 2010;3(2):101-8.
Bakris GL. Management of hypertension in patients with diabetes and chronic kidney disease. Diabetes Care. 2011;34(Supp 2):S210-4.
Inzucchi SE, et al. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA. 2014;312(24):2668-75.
Lipska KJ, et al. Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care. 2011;34(6):1431-7.
